Asiri Laboratories unveils world’s fastest Single Haematology Analyzer setting new era
Ada Derana: Designed to revolutionize blood disorder testing with unparalleled speed using advanced diagnosis technologies which enhances precision and accuracy, Asiri Laboratories unveiled the latest state-of-art Haematology Analyzer, Mindray BC-6800Plus, a cutting-edge instrument and world’s fastest standalone unit at its flagship laboratory at Asiri Medical Hospital in Colombo.
The innovative high-end analyzer promises to deliver unprecedented precision and efficiency in haematology testing, marking a significant milestone in the medical diagnostics industry and healthcare sector with enhanced patient care in the country.
In today’s healthcare landscape, laboratories need rapid, accurate results for increasingly complex blood disorders. The Mindray BC-6800Plus meets these challenges, offering unparalleled speed and precision. As the world’s fastest standalone haematology analyzer, it processes up to 200 samples per hour, with a 100-sample loading capacity. It also performs automated ESR testing at 120 samples per hour and body fluid testing at 40 samples per hour, signifying a paradigm shift in Sri Lanka’s haematology analysis capabilities.
Furthermore, coupled with Asiri Laboratories innovative solutions such as the introduction of the QR codes on receipts and test reports, a holistic approach to faster diagnoses and improved patient care align to international standards.
The Mindray BC-6800Plus offers cutting-edge features in a compact design, combining high-throughput capabilities with user-friendly operation. It processes samples in under 60 seconds, providing 37 reportable and 53 research parameters for whole blood, plus additional parameters for body fluids. The analyzer includes NRBC counting, reticulocyte analysis, and body fluid testing without extra reagents. Its SF Cube Technology ensures exceptional accuracy in cell counting and classification. With a storage capacity of 100,000 results and an automated quality control program, the BC-6800Plus guarantees high analytical precision while improving diagnostic accuracy, productivity, and patient care.
“The Mindray BC-6800Plus ushers in a new era for haematology diagnostics in Sri Lanka,” said Neil Priyath John, Director Laboratories of Asiri Hospital Holdings. “It enhances our diagnostic capabilities, offering more comprehensive and timely results. Its advanced features provide crucial information for various conditions, while improving efficiency with a user-friendly interface.”
He added, “As Sri Lanka’s leading private medical diagnostic chain for over 40 years, Asiri Laboratories’ investment in the Mindray BC-6800Plus demonstrates our commitment to innovation and excellence. The state-of-the-art hematology analyzer will set a new standard in the private healthcare sector, enabling more informed decisions and improved patient care.”
The introduction of the Hematology Analyzer is expected to have a profound impact on the diagnostics market. By offering a superior combination of speed, accuracy, and ease of use, the instrument is poised to set a new benchmark for hematology testing and with Asiri Laboratories network in over 120 locations island wide, the benefits of this technology will be accessible to a wide audience of customers in the country.
OSL take:
Sri Lanka’s healthcare industry has presented many business/investment opportunities to foreign businesses/investors given the industry is on an expansion path along with the country’s overall economic expansion. With Sri Lanka targeting on becoming a hub in the South Asian region, the opportunities in the healthcare industry are also on a growth path presenting many business/investment opportunities. The steady growth recorded by the country’s tourism industry as well as other key economic sectors has resulted in a growth in tourism arrivals to the country. Also, the promotion of health and wellness tourism has witnessed the arrival of tourists specifically for health reasons. All these have resulted in the steady growth in Sri Lanka’s healthcare industry and related sub sectors. Foreign businesses/investors could therefore confidently explore the expanding opportunities in Sri Lanka’s healthcare sector.